Latest news from Johnson & Johnson, Pharmaceuticals Group on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/rivaroxaban-record4-data-presented-at-efort/?sc=rsin /articles/rivaroxaban-record4-data-presented-at-efort/?sc=rsin Fri, 30 May 2008 11:30:00 EST Results from a pivotal Phase III clinical trial demonstrate that rivaroxaban, an oral, once-daily, investigational anticoagulant medication, was superior in preventing venous blood clots in patients who underwent total knee replacement (TKR) surgery. The head-to-head study compared rivaroxaban with the U.S.-approved dosing regimen for enoxaparin, the current standard of care. Johnson & Johnson, Pharmaceuticals Group /articles/investigational-anticoagulant-effective-in-preventing-venous-thromboembolism/?sc=rsin /articles/investigational-anticoagulant-effective-in-preventing-venous-thromboembolism/?sc=rsin Tue, 11 Dec 2007 09:00:00 EST Phase III clinical trial results underscore that rivaroxaban, the oral, once-daily, investigational anticoagulant, was significantly more effective than enoxaparin, the standard of care, in preventing venous thromboembolism (VTE) in patients undergoing total hip or knee replacement surgery. Johnson & Johnson, Pharmaceuticals Group /articles/what-modern-girls-should-know-about-the-pill/?sc=rsin /articles/what-modern-girls-should-know-about-the-pill/?sc=rsin Wed, 05 Dec 2007 09:00:00 EST It may be universally known as "the Pill," but how much do Modern Girls really know about this birth control choice? Modern Girl Author Jane Buckingham Pens New Guide on www.thepill.com. Johnson & Johnson, Pharmaceuticals Group /articles/most-people-living-with-hiv-experience-anemia/?sc=rsin /articles/most-people-living-with-hiv-experience-anemia/?sc=rsin Tue, 07 Aug 2001 00:00:00 EST Awareness of the symptoms, diagnosis and treatment of HIV-related anemia among people living with HIV remains alarmingly low according to the results of a first-of-its-kind survey of nearly 700 HIV-positive Americans. Johnson & Johnson, Pharmaceuticals Group